4//SEC Filing
MOORE GORDON EARLE 4
Accession 0001179110-12-012994
CIK 0000882095other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:32 PM ET
Size
13.7 KB
Accession
0001179110-12-012994
Insider Transaction Report
Form 4
MOORE GORDON EARLE
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2012-08-14−96,000→ 0 totalExercise: $15.70Exp: 2014-05-25→ Common Stock (96,000 underlying) - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2012-08-14−60,000→ 0 totalExercise: $19.43Exp: 2015-05-10→ Common Stock (60,000 underlying) - Exercise/Conversion
Common Stock
2012-08-14$8.50/sh+96,000$816,000→ 907,839 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2012-08-14$15.70/sh+96,000$1,507,200→ 1,003,839 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2012-08-14$19.43/sh+60,000$1,166,100→ 1,063,839 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2012-08-14−96,000→ 0 totalExercise: $8.50Exp: 2013-01-02→ Common Stock (96,000 underlying)
Footnotes (2)
- [F1]The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- [F2]Options are 100% vested on the date of grant.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0000908567
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:32 PM ET
- Size
- 13.7 KB